Gabapentin Capsule
Product Images NDC 63629-8486

Product Visual Gallery

This gallery contains 7 technical images submitted to the FDA as part of the official labeling for Gabapentin (NDC 63629-8486). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Bryant Ranch Prepack, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Figure 1 (Image 01)

Line graph showing mean pain scores over an 8-week period comparing placebo and Gabapentin at 3600 mg/day. The x-axis represents weeks from baseline to week 8, including a 4-week dose titration period and a 4-week fixed dose period. The y-axis shows mean pain scores ranging from 0 to 10. Gabapentin's pain scores decrease steadily, while placebo scores remain relatively stable.*

FDA Label Image

Figure 2 (Image 02)

Line graph depicting mean pain score over 7 weeks comparing placebo, Gabapentin 1800 mg/day, and Gabapentin 2400 mg/day. The x-axis shows time in weeks, including a 3-week dose titration period and a 4-week fixed dose period. The y-axis represents mean pain score, ranging from 0 to 10. Both Gabapentin doses show a decrease in pain score compared to placebo over time.*

FDA Label Image

Figure 3 (Image 03)

A bar graph titled 'Figure 3. Proportion of Responders (patients with ≥50% reduction in pain score) at Endpoint: Controlled PHN Studies' displays percentages from two studies. It compares placebo (PBO) and gabapentin (GBP) at doses of 1800, 2400, and 3600 mg, showing higher response rates for gabapentin groups in both studies, with statistical significance indicated by asterisks.*

FDA Label Image

Cockcroft And Gault Equation (Image 04)

Formula for calculating creatinine clearance (CLCr), using age, weight, serum creatinine, and a correction factor for female patients.*

FDA Label Image

Gabapentin Structural Formula (Image 05)

Chemical structure of gabapentin showing its molecular framework with a cyclohexane ring attached to aminomethyl and acetic acid functional groups.*

FDA Label Image

Image-09 (Image 09)

A scatter plot showing percentage difference versus daily dose (mg) for Gabapentin from three studies labeled Study a, Study b, and Study c. The daily dose ranges from 600 mg to 1800 mg, with differences plotted between approximately 5% and 20%, illustrating comparative data points across studies at multiple dose levels.*

FDA Label Image

Label (Lbl636298486)

Gabapentin Capsules, USP 300 mg oral capsules label showing the product strength prominently in a black and white box. The label includes the labeler Bryant Ranch Prepack, the NDC 63629-8486-1, and indicates a package quantity of 500 capsules. Storage and dispensing instructions are also present along with barcodes and manufacturer details.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.